Literatur
Confalonieri M et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med. 2005;171(3):242–8.
Snijders D, Daniels JM, de Graaff CS et al. Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med. 2010;181(9):975–82.
Fernández-Serrano S et al. Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial. Crit Care. 2011;15(2):R96.
Meijvis SC et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377(9782):2023–30.
Nie W et al. Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis. PlosOne. 2012;7(10):e47926.
Confalonieri M et al. Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia? Curr Infect Dis Rep. 2013;15:158–66.
Tagami T et al. Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients. Eur Respir J. 2015; 45(2):463–72
Blum CA et al. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2015 Jan 16. doi: 10.1016/S0138-6736(14)62447-8.
Literatur
Torres A, Sibila O, Ferrer M, Polverino E et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA 2015;313(7):677–86.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ott, S.R. Datenlage für Kortikosteroidgabe festigt sich. Pneumo News 7, 24–25 (2015). https://doi.org/10.1007/s15033-015-0138-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15033-015-0138-3